TNF Pharmaceuticals, Inc. Capital Reinvestment Ratio
TNF Pharmaceuticals, Inc. capital reinvestment ratio. TNF Pharmaceuticals, Inc. (TNFA) has a Capital Reinvestment Ratio of 0.44x as of December 2008, meaning it reinvests 0% of its operating cash flow ($469.37K) in capital expenditures ($208.51K). Check TNF Pharmaceuticals, Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of TNF Pharmaceuticals, Inc. (2007–2008)
Capital reinvestment ratio of TNF Pharmaceuticals, Inc. from 2007 to 2008. This chart tracks TNF Pharmaceuticals, Inc.'s Capital Reinvestment Ratio across 2 annual periods. Also explore net asset growth rate of TNF Pharmaceuticals, Inc. to track the company's year-over-year net asset growth rate.
TNF Pharmaceuticals, Inc. Capital Reinvestment Ratio by Year (2007–2008)
TNF Pharmaceuticals, Inc. capital reinvestment ratio by year from 2007 to 2008. For the full cash flow conversion analysis, see TNF Pharmaceuticals, Inc. (TNFA) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2008 | 0.44x | $469.37K | $208.51K | ▲ +285.6% |
| 2007 | 0.12x | $182.19K | $20.99K | — |